 |
 |

Results of Clinical Trials Sponsored by For-Profit vs Nonprofit Entities
 |
 |
| Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings. |
|
 |
 |
To the Editor: Dr Als-Nielsen and colleagues1 concluded that trials funded by for-profit organizations are more likely to have positive conclusions due to biased interpretation of trial results. Although Als-Nielsen et al found that trials funded by for-profit organizations more often demonstrate increased differences compared with control groups, they found that such trials are more likely to use placebos as a control, report a higher frequency of adverse effects, reach preplanned numbers of subjects, and be published in high-impact journals.
These results imply that for-profit organizations seem to plan and execute studies more rigorously than do nonprofit organizations. As a consequence, it seems that conclusions drawn from studies run by for-profit organizations are more trustworthy. This could be explained by the extensive guideline system governing for-profit organization trials, including the International Conference on Harmonisation (ICH) Good Clinical Practice guidelines2 and others. Studies performed by for-profit organizations are very often used . . . [Full Text of this Article]
Stig Waldorff, MD
Clinical Research Committee The Danish Association of the Pharmaceutical Industry Copenhagen, Denmark
CiteULike Connotea Del.icio.us Digg Reddit Technorati Twitter
What's this?
RELATED ARTICLES
Results of Clinical Trials Sponsored by For-Profit vs Nonprofit Entities
Robert H. Palmer
JAMA. 2003;290(23):3070.
EXTRACT
| FULL TEXT
Results of Clinical Trials Sponsored by For-Profit vs Nonprofit Entities
Jonathan B. Rosefsky
JAMA. 2003;290(23):3070-3071.
EXTRACT
| FULL TEXT
Results of Clinical Trials Sponsored by For-Profit vs Nonprofit EntitiesReply
Bodil Als-Nielsen, Wendong Chen, Christian Gluud, and Lise Lotte Kjaergard
JAMA. 2003;290(23):3071-3072.
EXTRACT
| FULL TEXT
Association of Funding and Conclusions in Randomized Drug Trials: A Reflection of Treatment Effect or Adverse Events?
Bodil Als-Nielsen, Wendong Chen, Christian Gluud, and Lise L. Kjaergard
JAMA. 2003;290(7):921-928.
ABSTRACT
| FULL TEXT
|